Serious adverse events
|
LY 2127399 Q2W Treatment |
LY2127399 Q4W Treatment Period |
LY 2127399 Q2W Follow Up |
LY2127399 Q4W Follow Up |
Total subjects affected by serious adverse events
|
|
|
|
|
subjects affected / exposed
|
129 / 937 (13.77%) |
64 / 578 (11.07%) |
41 / 810 (5.06%) |
38 / 526 (7.22%) |
number of deaths (all causes)
|
5 |
2 |
2 |
2 |
number of deaths resulting from adverse events
|
1 |
0 |
1 |
0 |
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
|
|
basal cell carcinoma
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
benign breast neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
benign vaginal neoplasm
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [1]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
breast cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
brenner tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [2]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
haemangioma
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
neuroendocrine tumour
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
prostate cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [3]
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 50 (0.00%) |
1 / 44 (2.27%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
squamous cell carcinoma of skin
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
squamous cell carcinoma of the cervix
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [4]
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 760 (0.00%) |
1 / 482 (0.21%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
uterine cancer
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [5]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
uterine leiomyoma
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [6]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Vascular disorders
|
|
|
|
|
deep vein thrombosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
extremity necrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
4 / 937 (0.43%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hypotension
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
orthostatic hypotension
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
peripheral arterial occlusive disease
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
poor venous access
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
shock haemorrhagic
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
thrombophlebitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
vasculitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
venous occlusion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
venous thrombosis limb
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Pregnancy, puerperium and perinatal conditions
|
|
|
|
|
abortion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [7]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
abortion spontaneous
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [8]
|
1 / 877 (0.11%) |
1 / 527 (0.19%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
blighted ovum
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [9]
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 760 (0.00%) |
1 / 482 (0.21%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
ectopic pregnancy
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [10]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
1 / 760 (0.13%) |
0 / 482 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
General disorders and administration site conditions
|
|
|
|
|
death
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
device dislocation
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
implant site erosion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
medical device complication
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
non-cardiac chest pain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
3 / 810 (0.37%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pelvic mass
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pyrexia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
2 / 810 (0.25%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Immune system disorders
|
|
|
|
|
drug hypersensitivity
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Reproductive system and breast disorders
|
|
|
|
|
benign prostatic hyperplasia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [11]
|
0 / 60 (0.00%) |
1 / 51 (1.96%) |
0 / 50 (0.00%) |
1 / 44 (2.27%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
dysmenorrhoea
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [12]
|
0 / 877 (0.00%) |
1 / 527 (0.19%) |
0 / 760 (0.00%) |
1 / 482 (0.21%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
metrorrhagia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [13]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
ovarian cyst
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [14]
|
0 / 877 (0.00%) |
1 / 527 (0.19%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory, thoracic and mediastinal disorders
|
|
|
|
|
acute respiratory distress syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
acute respiratory failure
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
asthma
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
atelectasis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
chronic obstructive pulmonary disease
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
4 / 937 (0.43%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
dyspnoea
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
haemoptysis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hypoxia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
interstitial lung disease
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pleural effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pleural fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pulmonary congestion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pulmonary embolism
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
2 / 810 (0.25%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pulmonary haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
pulmonary hypertension
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pulmonary oedema
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
upper airway obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Psychiatric disorders
|
|
|
|
|
anxiety
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
conversion disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
delirium tremens
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
depression
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
generalised anxiety disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
mental status changes
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
suicide attempt
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Investigations
|
|
|
|
|
electrocardiogram qrs complex shortened
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
lipase increased
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Injury, poisoning and procedural complications
|
|
|
|
|
ankle fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bone fissure
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bronchial injury
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
concussion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
contusion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
fall
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
femoral neck fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
femur fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
fibula fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gun shot wound
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
head injury
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
joint injury
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
ligament rupture
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
ligament sprain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
muscle strain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
overdose
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
procedural intestinal perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
respiratory fume inhalation disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
road traffic accident
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
spinal compression fracture
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
subdural haematoma
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
vascular pseudoaneurysm
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac disorders
|
|
|
|
|
acute myocardial infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
angina pectoris
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
atrioventricular block
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
atrioventricular block complete
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
atrioventricular block second degree
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bundle branch block bilateral
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cardiac arrest
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
cardiac failure congestive
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cardio-respiratory arrest
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
coronary artery disease
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
myocardial fibrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
myocardial infarction
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pericardial effusion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pericarditis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
right ventricular failure
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
tachycardia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
tricuspid valve disease
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Nervous system disorders
|
|
|
|
|
autonomic nervous system imbalance
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
carotid artery dissection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cerebrovascular disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
epilepsy
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
headache
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hemiparesis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
iiird nerve disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
migraine
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
neuropathy peripheral
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
neuropsychiatric lupus
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
optic neuritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
subarachnoid haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
syncope
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
tension headache
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
transient ischaemic attack
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
viith nerve paralysis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
vith nerve disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Blood and lymphatic system disorders
|
|
|
|
|
anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
anaemia macrocytic
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
autoimmune haemolytic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
febrile neutropenia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
haemolytic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
haemolytic uraemic syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
haemorrhagic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
histiocytosis haematophagic
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
iron deficiency anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
leukopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
lymphopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
microcytic anaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
neutropenia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
1 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
thrombocytopenia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
thrombotic thrombocytopenic purpura
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Ear and labyrinth disorders
|
|
|
|
|
vertigo
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Eye disorders
|
|
|
|
|
amaurosis fugax
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cataract
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
diplopia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
eyelid ptosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal disorders
|
|
|
|
|
abdominal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
4 / 937 (0.43%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 4 |
1 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
colitis ulcerative
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
constipation
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gastric ulcer perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gastritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gastritis erosive
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gastrointestinal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gastrooesophageal reflux disease
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
haemorrhoidal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hiatus hernia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
intestinal ischaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
intestinal perforation
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
large intestine polyp
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
oesophagitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pancreatitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pancreatitis acute
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
rectal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
retroperitoneal haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
small intestinal obstruction
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Hepatobiliary disorders
|
|
|
|
|
cholecystitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cholecystitis acute
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cholecystitis chronic
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cholelithiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
drug-induced liver injury
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hepatic function abnormal
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
liver disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
nodular regenerative hyperplasia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Skin and subcutaneous tissue disorders
|
|
|
|
|
angioedema
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
dry gangrene
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
mucocutaneous ulceration
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
precancerous skin lesion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
psoriasis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
skin ulcer
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Renal and urinary disorders
|
|
|
|
|
bladder prolapse
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
calculus ureteric
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
glomerulonephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hydronephrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
lupus nephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
2 / 810 (0.25%) |
3 / 526 (0.57%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
nephrolithiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
renal failure acute
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
urinary retention
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Endocrine disorders
|
|
|
|
|
adrenal insufficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
adrenocortical insufficiency acute
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
mineralocorticoid deficiency
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Musculoskeletal and connective tissue disorders
|
|
|
|
|
arthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
back pain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bursitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
chondrocalcinosis pyrophosphate
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
costochondritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
intervertebral disc protrusion
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
lumbar spinal stenosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
muscle haemorrhage
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
muscular weakness
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
musculoskeletal chest pain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
musculoskeletal pain
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
osteoarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
osteonecrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
8 / 937 (0.85%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pain in extremity
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
sle arthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
spinal osteoarthritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
systemic lupus erythematosus
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
4 / 937 (0.43%) |
3 / 578 (0.52%) |
1 / 810 (0.12%) |
4 / 526 (0.76%) |
occurrences causally related to treatment / all
|
0 / 4 |
1 / 4 |
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
tendon disorder
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Infections and infestations
|
|
|
|
|
abdominal abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
amoebiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
appendicitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
2 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
arthritis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bacteraemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
blastocystis infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
brain abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bronchitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
bronchitis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cellulitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cervicitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [15]
|
0 / 877 (0.00%) |
1 / 527 (0.19%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
cytomegalovirus infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
diverticulitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
enterocolitis bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
escherichia urinary tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
gastroenteritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
2 / 937 (0.21%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
groin abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
herpes zoster
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
2 / 526 (0.38%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
herpes zoster disseminated
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
infectious colitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
influenza
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
kidney infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
lobar pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
localised infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
meningitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
meningitis cryptococcal
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
meningitis viral
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
oesophageal candidiasis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
ophthalmic herpes zoster
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
oral fungal infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
peritonitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
peritonsillar abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pharyngotonsillitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pneumococcal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pneumonia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
11 / 937 (1.17%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
8 / 12 |
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
pneumonia bacterial
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
post procedural infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pulmonary tuberculosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
0 / 0 |
pyelonephritis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
pyonephrosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
respiratory tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
1 / 578 (0.17%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
sepsis syndrome
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
septic shock
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
sinusitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
staphylococcal sepsis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
staphylococcal skin infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
subcutaneous abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
tooth abscess
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
upper respiratory tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
2 / 3 |
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
urinary tract infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
3 / 937 (0.32%) |
3 / 578 (0.52%) |
2 / 810 (0.25%) |
3 / 526 (0.57%) |
occurrences causally related to treatment / all
|
2 / 3 |
2 / 3 |
2 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
varicella
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
1 / 578 (0.17%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
viral infection
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
vulval cellulitis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed [16]
|
1 / 877 (0.11%) |
0 / 527 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
Metabolism and nutrition disorders
|
|
|
|
|
cholesterosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
dehydration
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
diabetes mellitus
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
1 / 526 (0.19%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
diabetes mellitus inadequate control
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hyperglycaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
hypoglycaemia
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
2 / 578 (0.35%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
ketosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
1 / 937 (0.11%) |
0 / 578 (0.00%) |
0 / 810 (0.00%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |
metabolic acidosis
|
|
|
|
|
alternative dictionary used: MedDRA
17.1
|
|
|
|
|
subjects affected / exposed
|
0 / 937 (0.00%) |
0 / 578 (0.00%) |
1 / 810 (0.12%) |
0 / 526 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
0 / 0 |